Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-20-000520
Filing Date
2020-05-29
Accepted
2020-05-29 12:45:53
Documents
1
Period of Report
2020-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_6713.html 4  
1 PRIMARY DOCUMENT doc4_6713.xml 4 7390
  Complete submission text file 0001638599-20-000520.txt   8947
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IBIO, INC. 600 MADISON AVE., SUITE 1601 NEW YORK NY 10022
Business Address
Mullaney James P. (Reporting) CIK: 0001702906 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 20925664